151 related articles for article (PubMed ID: 35075986)
21. A genome-wide aberrant RNA splicing in patients with acute myeloid leukemia identifies novel potential disease markers and therapeutic targets.
Adamia S; Haibe-Kains B; Pilarski PM; Bar-Natan M; Pevzner S; Avet-Loiseau H; Lode L; Verselis S; Fox EA; Burke J; Galinsky I; Dagogo-Jack I; Wadleigh M; Steensma DP; Motyckova G; Deangelo DJ; Quackenbush J; Stone R; Griffin JD
Clin Cancer Res; 2014 Mar; 20(5):1135-45. PubMed ID: 24284058
[TBL] [Abstract][Full Text] [Related]
22. Genome-wide identification of aberrant alternative splicing and RNA-binding protein regulators in acute myeloid leukaemia which may contribute to immune microenvironment remodelling.
Yang Y; Zhang YM; Wang Y; Liu K; Cui SY; Luo YQ; Zheng W; Xu J; Duan W; Wang JY
Carcinogenesis; 2023 Aug; 44(5):418-425. PubMed ID: 37209099
[TBL] [Abstract][Full Text] [Related]
23. miR-34b Targets HSF1 to Suppress Cell Survival in Acute Myeloid Leukemia.
Li G; Song Y; Zhang Y; Wang H; Xie J
Oncol Res; 2016; 24(2):109-16. PubMed ID: 27296951
[TBL] [Abstract][Full Text] [Related]
24. DEK oncogene expression during normal hematopoiesis and in Acute Myeloid Leukemia (AML).
Logan GE; Mor-Vaknin N; Braunschweig T; Jost E; Schmidt PV; Markovitz DM; Mills KI; Kappes F; Percy MJ
Blood Cells Mol Dis; 2015 Jan; 54(1):123-31. PubMed ID: 25128083
[TBL] [Abstract][Full Text] [Related]
25. Advances in Understanding the Links between Metabolism and Autophagy in Acute Myeloid Leukemia: From Biology to Therapeutic Targeting.
Saulle E; Spinello I; Quaranta MT; Labbaye C
Cells; 2023 Jun; 12(11):. PubMed ID: 37296673
[TBL] [Abstract][Full Text] [Related]
26. SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice.
Ma Y; Cui W; Yang J; Qu J; Di C; Amin HM; Lai R; Ritz J; Krause DS; Chai L
Blood; 2006 Oct; 108(8):2726-35. PubMed ID: 16763212
[TBL] [Abstract][Full Text] [Related]
27. Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia.
Kharas MG; Lengner CJ; Al-Shahrour F; Bullinger L; Ball B; Zaidi S; Morgan K; Tam W; Paktinat M; Okabe R; Gozo M; Einhorn W; Lane SW; Scholl C; Fröhling S; Fleming M; Ebert BL; Gilliland DG; Jaenisch R; Daley GQ
Nat Med; 2010 Aug; 16(8):903-8. PubMed ID: 20616797
[TBL] [Abstract][Full Text] [Related]
28. Expression, Regulation and Function of microRNA as Important Players in the Transition of MDS to Secondary AML and Their Cross Talk to RNA-Binding Proteins.
Bauer M; Vaxevanis C; Heimer N; Al-Ali HK; Jaekel N; Bachmann M; Wickenhauser C; Seliger B
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992663
[TBL] [Abstract][Full Text] [Related]
29. MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML.
Heuser M; Argiropoulos B; Kuchenbauer F; Yung E; Piper J; Fung S; Schlenk RF; Dohner K; Hinrichsen T; Rudolph C; Schambach A; Baum C; Schlegelberger B; Dohner H; Ganser A; Humphries RK
Blood; 2007 Sep; 110(5):1639-47. PubMed ID: 17494859
[TBL] [Abstract][Full Text] [Related]
30. Activation of the unfolded protein response in human acute myeloid leukemia.
Schardt JA; Mueller BU; Pabst T
Methods Enzymol; 2011; 489():227-43. PubMed ID: 21266233
[TBL] [Abstract][Full Text] [Related]
31. RNA-binding protein IGF2BP3 targeting of oncogenic transcripts promotes hematopoietic progenitor proliferation.
Palanichamy JK; Tran TM; Howard JM; Contreras JR; Fernando TR; Sterne-Weiler T; Katzman S; Toloue M; Yan W; Basso G; Pigazzi M; Sanford JR; Rao DS
J Clin Invest; 2016 Apr; 126(4):1495-511. PubMed ID: 26974154
[TBL] [Abstract][Full Text] [Related]
32. Functional inhibition of mesenchymal stromal cells in acute myeloid leukemia.
Geyh S; Rodríguez-Paredes M; Jäger P; Khandanpour C; Cadeddu RP; Gutekunst J; Wilk CM; Fenk R; Zilkens C; Hermsen D; Germing U; Kobbe G; Lyko F; Haas R; Schroeder T
Leukemia; 2016 Mar; 30(3):683-91. PubMed ID: 26601782
[TBL] [Abstract][Full Text] [Related]
33. Post-transcriptional regulation in hematopoiesis: RNA binding proteins take control
de Rooij LPMH; Chan DCH; Keyvani Chahi A; Hope KJ
Biochem Cell Biol; 2019 Feb; 97(1):10-20. PubMed ID: 29898370
[TBL] [Abstract][Full Text] [Related]
34. Targeting Oncogenic Super Enhancers in MYC-Dependent AML Using a Small Molecule Activator of NR4A Nuclear Receptors.
Call SG; Duren RP; Panigrahi AK; Nguyen L; Freire PR; Grimm SL; Coarfa C; Conneely OM
Sci Rep; 2020 Feb; 10(1):2851. PubMed ID: 32071334
[TBL] [Abstract][Full Text] [Related]
35. The AAA+ATPase RUVBL2 is essential for the oncogenic function of c-MYB in acute myeloid leukemia.
Armenteros-Monterroso E; Zhao L; Gasparoli L; Brooks T; Pearce K; Mansour MR; Martens JHA; de Boer J; Williams O
Leukemia; 2019 Dec; 33(12):2817-2829. PubMed ID: 31138842
[TBL] [Abstract][Full Text] [Related]
36. Transcriptional control of CBX5 by the RNA binding proteins RBMX and RBMXL1 maintains chromatin state in myeloid leukemia.
Prieto C; Nguyen DTT; Liu Z; Wheat J; Perez A; Gourkanti S; Chou T; Barin E; Velleca A; Rohwetter T; Chow A; Taggart J; Savino AM; Hoskova K; Dhodapkar M; Schurer A; Barlowe TS; Vu LP; Leslie C; Steidl U; Rabadan R; Kharas MG
Nat Cancer; 2021 Jul; 2():741-757. PubMed ID: 34458856
[TBL] [Abstract][Full Text] [Related]
37. LncRNA KCNQ1OT1 controls cell proliferation, differentiation and apoptosis by sponging miR-326 to regulate c-Myc expression in acute myeloid leukemia.
Cheng P; Lu P; Guan J; Zhou Y; Zou L; Yi X; Cheng H
Neoplasma; 2020 Mar; 67(2):238-248. PubMed ID: 31390869
[TBL] [Abstract][Full Text] [Related]
38. AML1-ETO targets and suppresses cathepsin G, a serine protease, which is able to degrade AML1-ETO in t(8;21) acute myeloid leukemia.
Jin W; Wu K; Li YZ; Yang WT; Zou B; Zhang F; Zhang J; Wang KK
Oncogene; 2013 Apr; 32(15):1978-87. PubMed ID: 22641217
[TBL] [Abstract][Full Text] [Related]
39. Long noncoding RNA HOXA-AS2 functions as an oncogene by binding to EZH2 and suppressing LATS2 in acute myeloid leukemia (AML).
Feng Y; Hu S; Li L; Peng X; Chen F
Cell Death Dis; 2020 Dec; 11(12):1025. PubMed ID: 33268767
[TBL] [Abstract][Full Text] [Related]
40. Significance of oncogenes and tumor suppressor genes in AML prognosis.
Kavianpour M; Ahmadzadeh A; Shahrabi S; Saki N
Tumour Biol; 2016 Aug; 37(8):10041-52. PubMed ID: 27179964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]